Mediclinic International’s biggest shareholder believes there’s still room for healing.

At its investor presentation last month, Remgro — which holds a commanding 44.6% stake in the private hospitals group — indicated Mediclinic is firmly in the group’s "turnaround bucket". And while it’s too early to say how long that turnaround will take, the group is cautiously optimistic, says CEO Jannie Durand...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.